• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cell . Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity

tetano

Editor, Senior Moderator
Cell


. 2020 Sep 16;S0092-8674(20)31235-6.
doi: 10.1016/j.cell.2020.09.038. Online ahead of print.
Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity


Carolyn Rydyznski Moderbacher[SUP] 1 [/SUP], Sydney I Ramirez[SUP] 2 [/SUP], Jennifer M Dan[SUP] 2 [/SUP], Alba Grifoni[SUP] 1 [/SUP], Kathryn M Hastie[SUP] 1 [/SUP], Daniela Weiskopf[SUP] 1 [/SUP], Simon Belanger[SUP] 1 [/SUP], Robert K Abbott[SUP] 1 [/SUP], Christina Kim[SUP] 1 [/SUP], Jinyong Choi[SUP] 1 [/SUP], Yu Kato[SUP] 1 [/SUP], Eleanor G Crotty[SUP] 1 [/SUP], Cheryl Kim[SUP] 3 [/SUP], Stephen A Rawlings[SUP] 4 [/SUP], Jose Mateus[SUP] 1 [/SUP], Long Ping Victor Tse[SUP] 5 [/SUP], April Frazier[SUP] 1 [/SUP], Ralph Baric[SUP] 6 [/SUP], Bjoern Peters[SUP] 1 [/SUP], Jason Greenbaum[SUP] 1 [/SUP], Erica Ollmann Saphire[SUP] 2 [/SUP], Davey M Smith[SUP] 4 [/SUP], Alessandro Sette[SUP] 7 [/SUP], Shane Crotty[SUP] 8 [/SUP]



Affiliations
Free PMC article

Abstract

Limited knowledge is available on the relationship between antigen-specific immune responses and COVID-19 disease severity. We completed a combined examination of all three branches of adaptive immunity at the level of SARS-CoV-2-specific CD4[SUP]+[/SUP] and CD8[SUP]+[/SUP] T cell and neutralizing antibody responses in acute and convalescent subjects. SARS-CoV-2-specific CD4[SUP]+[/SUP] and CD8[SUP]+[/SUP] T cells were each associated with milder disease. Coordinated SARS-CoV-2-specific adaptive immune responses were associated with milder disease, suggesting roles for both CD4[SUP]+[/SUP] and CD8[SUP]+[/SUP] T cells in protective immunity in COVID-19. Notably, coordination of SARS-CoV-2 antigen-specific responses was disrupted in individuals ≥ 65 years old. Scarcity of naive T cells was also associated with aging and poor disease outcomes. A parsimonious explanation is that coordinated CD4[SUP]+[/SUP] T cell, CD8[SUP]+[/SUP] T cell, and antibody responses are protective, but uncoordinated responses frequently fail to control disease, with a connection between aging and impaired adaptive immune responses to SARS-CoV-2.

Keywords: CD4; CD8; CXCL10; IP-10; Spike; T cells; adaptive immunity; antibody; coronavirus; epitopes; neutralizing antibodies.
 
Back
Top Bottom